👉🏻Increased use of older DCD donors in US Liver Transplantation Older DCDs are currently the fastest growing donor group in the US. https://t.co/rHBMN9CSW5 @Paulo_MartinsMD @E_CalderonMD @DimitriosMoris @MathurAmitK #C_Desai @hpbjournal @_ILTS_ @IHPBA @ASTSChimera

Food for thought or maybe call for action. Reimagining Academic Surgery: The Case for International medical graduates @ManosGiorgakis @IA_Ziogas @Paulo_MartinsMD @AnnalsofSurgery

Call for action piece publish in @SurgJournal @ManosGiorgakis Reviving Greek surgery: Toward competency, innovation, and global integration - Surgery

Call for action published in @SurgJournal with @ManosGiorgakis. Modernizing surgical education in Greece: Bridging the gap to global standards - Surgery

Extremely proud to announce the launch of our robotic kidney transplant program @UNCSurgery !!! 2 transplants completed and more to come!!! Great team effort !!! @ASTSChimera Special thanks to @moeltemamy https://t.co/NIAyLBRRMf

“Multiple center listing for organ transplantation in the United States: time to reform?“ United States is the only country allowing multi center listing. In this paper we analyze the pros and cons of this system. Paper by @ManosGiorgakis @KerenLadin @DimitriosMoris

This year’s medicine laureate Shimon Sakaguchi discovered a new class of T cells. Sakaguchi was swimming against the tide in 1995, when he made a key discovery. At the time, many researchers were convinced that immune tolerance only developed due to potentially harmful immune

From Heritage to Global Presence: The Case for a PubMed-Indexed Greek Surgical Journal https://t.co/aUungqf3Oc @ManosGiorgakis

The liver is the best organ 😎

I am very thrilled to see after a long time my third book as an editor published. This book bridges regenerative hepatology and transplant medicine. It illustrates the state of the art of clinical liver transplantation, as well as of the progress of regenerative medicine

Important first-in-human report today for donor pancreatic islet beta-cell transplant to an individual w/Type 1 diabetes. With genome editing of the cells, there was no immune response induced or need for immunosuppression. Major implications for transplantation in general @NEJM

Stem Cell–Derived, Fully Differentiated #Islets for #T1DM @NEJM

Simultaneous kidney and stem cell transplants Induction of immune tolerance in living related human leukocyte antigen–matched kidney transplantation: A phase 3 randomized clinical trial - @amjtransplant @MayoTransplant

Οὐ γὰρ δοκεῖν ἄριστος, ἀλλ᾽ εἶναι θέλει Αισχύλος ( Επτά επί Θήβας) Not to seem noble, but to be one. Aeschylus

Proud to share our🔥article regarding #HIV D+/R+ #Liver and #Kidney Txp just published in @amjtransplant 🔗 https://t.co/3yrtTDkmjy(🆓download before 7/18) It was an honor to present this article and other issues regarding #MASLD in people with #HIV @UTHSA_AETC last Friday! So

Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https://t.co/4WOqQUIv3S @ADA_DiabetesPro | #ADASciSessions

«First, tell yourself who you want to be; then act accordingly.» - Epictetus, Discourses (Original text, Ancient Greek) «Τίς εἶναι θέλεις, σαυτῷ πρῶτον εἰπέ· εἶθ' ��ὕτως ποίει ἃ ποιεῖς.» - Επίκτητος, Διατριβαί

Hot off the press! Our latest study "Transforming the logistics of liver transplantation with normothermic machine perfusion: Clinical impact versus cost" has just been published in @LTxJournal. Read here; https://t.co/vbSRSaxzyE @drewbarbz @Qimeng6 @IsaacAlderete5 @NihalAykun

🚨 Don't miss this timely review on hepatocellular carcinoma! Evolving treatments—including surgery, locoregional therapy & immunotherapy—may offer curative options for advanced disease. Explore the article: https://t.co/npgc70z8qH @michael_lidsky @DimitriosMoris @OncoAlert